Credit Suisse’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-80,208
| Closed | -$13.3M | – | 4688 |
|
|
2021
Q2 | $13.3M | Sell |
80,208
-24,335
| -23% | -$4.06M | 0.01% | 1381 |
|
|
2021
Q1 | $16M | Buy |
104,543
+20,443
| +24% | +$2.78M | 0.01% | 1287 |
|
|
2020
Q4 | $10.5M | Sell |
84,100
-3,731
| -4% | -$417K | 0.01% | 1539 |
|
|
2020
Q3 | $8.91M | Buy |
87,831
+232
| +0.3% | +$23.7K | 0.01% | 1441 |
|
|
2020
Q2 | $8.52M | Sell |
87,599
-228,423
| -72% | -$21.3M | 0.01% | 1383 |
|
|
2020
Q1 | $26.2M | Sell |
316,022
-136,124
| -30% | -$13.3M | 0.02% | 700 |
|
|
2019
Q4 | $50.3M | Sell |
452,146
-34,384
| -7% | -$3.54M | 0.04% | 556 |
|
|
2019
Q3 | $48.3M | Sell |
486,530
-84,773
| -15% | -$8.42M | 0.04% | 469 |
|
|
2019
Q2 | $56.6M | Sell |
571,303
-31,779
| -5% | -$3.03M | 0.05% | 387 |
|
|
2019
Q1 | $66.5M | Sell |
603,082
-11,293
| -2% | -$1.18M | 0.06% | 314 |
|
|
2018
Q4 | $56.5M | Buy |
614,375
+8,398
| +1% | +$850K | 0.06% | 337 |
|
|
2018
Q3 | $66.8M | Buy |
605,977
+102,041
| +20% | +$10.6M | 0.06% | 328 |
|
|
2018
Q2 | $47M | Sell |
503,936
-263,619
| -34% | -$22.7M | 0.05% | 408 |
|
|
2018
Q1 | $63.7M | Buy |
767,555
+288,061
| +60% | +$25.6M | 0.06% | 342 |
|
|
2017
Q4 | $43.7M | Buy |
479,494
+291,394
| +155% | +$24.2M | 0.04% | 491 |
|
|
2017
Q3 | $14.3M | Sell |
188,100
-78,628
| -29% | -$5.94M | 0.01% | 1039 |
|
|
2017
Q2 | $20M | Sell |
266,728
-96,283
| -27% | -$6.67M | 0.02% | 805 |
|
|
2017
Q1 | $23.7M | Buy |
363,011
+73,886
| +26% | +$4.35M | 0.02% | 741 |
|
|
2016
Q4 | $15.9M | Buy |
289,125
+242,524
| +520% | +$13.3M | 0.02% | 930 |
|
|
2016
Q3 | $2.63M | Sell |
46,601
-12,088
| -21% | -$593K | ﹤0.01% | 2174 |
|
|
2016
Q2 | $2.45M | Buy |
58,689
+37,623
| +179% | +$1.73M | ﹤0.01% | 2179 |
|
|
2016
Q1 | $901K | Sell |
21,066
-14,120
| -40% | -$597K | ﹤0.01% | 2807 |
|
|
2015
Q4 | $1.59M | Buy |
35,186
+23,851
| +210% | +$1M | ﹤0.01% | 2443 |
|
|
2015
Q3 | $441K | Sell |
11,335
-5,102
| -31% | -$204K | ﹤0.01% | 3487 |
|
|
2015
Q2 | $598K | Buy |
16,437
+2,842
| +21% | +$89.9K | ﹤0.01% | 3593 |
|
|
2015
Q1 | $392K | Buy |
+13,595
| New | +$379K | ﹤0.01% | 3707 |
|
Other funds holding PRAH
Credit Suisse's PRAH Position: Q3 2021 in Review
Credit Suisse sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 80,208 shares — an estimated $13.3M sold.
Credit Suisse first reported a position in PRAH in Q1 2015 and held it in 26 quarters. The position peaked at $66.8M in Q3 2018. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Credit Suisse reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Credit Suisse sold 80,208 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $13.3M.
- Credit Suisse first reported a position in PRA Health Sciences, Inc. in Q1 2015 and held it in 26 quarters.
- Credit Suisse's PRA Health Sciences, Inc. position peaked at $66.8M in Q3 2018.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Credit Suisse's 13F filing for Q3 2021, filed 12 Nov 2021.